Deming Sun Selected Research

interstitial retinol-binding protein

12/2021	Vaccination with circulating exosomes in autoimmune uveitis prevents recurrent intraocular inflammation.
1/2017	The HMGB1-CXCL12 Complex Promotes Inflammatory Cell Infiltration in Uveitogenic T Cell-Induced Chronic Experimental Autoimmune Uveitis.
11/2016	TLR7 Engagement on Dendritic Cells Enhances Autoreactive Th17 Responses via Activation of ERK.
9/2015	HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent.
12/2014	Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent.
9/2011	IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis.
9/2007	Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
4/2006	Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis.
6/2005	Chronic recurrent autoimmune uveitis with progressive photoreceptor damage induced in rats by transfer of IRBP-specific T cells.
11/2003	CpG-containing oligodeoxynucleotide 1826 converts the weak uveitogenic rat interphotoreceptor retinoid-binding protein peptide 1181-1191 into a strong uveitogen.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deming Sun Research Topics

Disease

37	Uveitis 12/2021 - 11/2002
15	Inflammation (Inflammations) 01/2022 - 02/2003
8	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2003
3	Encephalomyelitis (Myeloencephalitis) 08/2004 - 11/2002
2	Dacryocystitis (Dacryoadenitis) 01/2022 - 01/2020
2	Dry Eye Syndromes (Dry Eye Syndrome) 01/2022 - 01/2020
2	Neoplasms (Cancer) 09/2007 - 09/2005
2	Anterior Uveitis 11/2002 - 11/2002
1	Infections 01/2018
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2014
1	Experimental Arthritis 03/2013
1	Keratitis 01/2012
1	Hypersensitivity (Allergy) 12/2009
1	Keratoconjunctivitis Sicca 05/2009
1	Disease Susceptibility (Diathesis) 03/2009
1	Communicable Diseases (Infectious Diseases) 09/2007
1	Optic Neuritis (Retrobulbar Neuritis) 11/2004
1	Paralysis (Palsy) 02/2003
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2002

Drug/Important Bio-Agent (IBA)

12	interstitial retinol-binding proteinIBA 12/2021 - 06/2003
10	Peptides (Polypeptides)IBA 12/2021 - 11/2002
7	AntigensIBA 12/2021 - 11/2002
7	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 12/2014
7	Retinaldehyde (Retinal)IBA 01/2021 - 02/2006
7	Interleukin-17 (Interleukin 17)IBA 11/2016 - 03/2009
5	CytokinesIBA 12/2021 - 03/2009
5	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021 - 01/2014
3	LigandsIBA 01/2022 - 01/2012
3	Adenosine DeaminaseIBA 01/2021 - 03/2016
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 01/2016
3	HMGB1 Protein (HMG1)IBA 01/2017 - 04/2014
3	Myelin-Oligodendrocyte GlycoproteinIBA 11/2004 - 11/2002
2	EnzymesIBA 01/2021 - 01/2016
2	Therapeutic UsesIBA 01/2020 - 01/2016
2	AutoantigensIBA 02/2012 - 05/2009
2	Proteins (Proteins, Gene)FDA Link 06/2003 - 02/2003
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Fenofibrate (CiL)FDA LinkGeneric 01/2022
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2022
1	Volatile Fatty AcidsIBA 01/2021
1	EndotoxinsIBA 01/2021
1	LipopolysaccharidesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 12/2019
1	1-nitrosoindole-3-acetonitrileIBA 12/2019
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2016
1	Adenosine Monophosphate (AMP)IBA 01/2016
1	2',3'-dialdehyde ATPIBA 01/2016
1	insulin B (9-23)IBA 08/2014
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2014
1	Interleukin-23 (Interleukin 23)IBA 08/2013
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2013
1	Hormones (Hormone)IBA 01/2012
1	Toll-Like Receptor 3IBA 01/2012
1	Interleukin-10 (Interleukin 10)IBA 03/2011
1	VaccinesIBA 09/2007
1	Leukotriene B4IBA 04/2006
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 04/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 09/2005
1	OligodeoxyribonucleotidesIBA 11/2003
1	Lymphotoxin-alpha (Lymphotoxin)IBA 06/2003
1	Lymphotoxin beta ReceptorIBA 06/2003
1	Amino Acids FDA Link 02/2003
1	Myelin ProteinsIBA 11/2002
1	B7 AntigensIBA 11/2002
1	Myelin Basic ProteinIBA 11/2002

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2003
1	Transjugular Intrahepatic Portasystemic Shunt 01/2021
1	Ligation 01/2021
1	Immunomodulation 01/2021
1	Intracameral Injection 12/2009
1	Intraocular Injections 12/2009